UNSPSC 51182012: Androstenolone or dehydroepiandrosterone or DHEA or prasterone

This classification denotes a therapeutic androgen, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 459AG36T1B. European Medicines Agency schedules Dehydroepiandrosterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10002MIG. Prasterone generally arises in the molecular formula C19H28O2.

The term PRASTERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, no 10 1978, list 18.) PRASTERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O=C1C2(C(C3C(C4(C(=CC3)CC(O)CC4)C)CC2)CC1)C.

UNSPSC 51182012 Androstenolone or dehydroepiandrosterone or DHEA or prasterone is a Commodity code representing a single pharmaceutical steroid compound used in hormone replacement therapy and clinical applications. State and local procurement activity under this code is minimal; the source contains no recent state or local contract opportunities soliciting this substance. Without posted solicitations naming this code, the scope and issuing-body composition cannot be reliably characterized from recent market activity.

Geographic spread and representative recent opportunities cannot be determined from the available source material, as no recent state or local opportunities are documented under this code.